TLPPF (Telix Pharmaceuticals) Price-to-Operating-Cash-Flow : 190.79 (As of May. 31, 2025)

View and export this data going back to 2018. Start your Free Trial

What is Telix Pharmaceuticals Price-to-Operating-Cash-Flow?

As of today (2025-05-31), Telix Pharmaceuticals's share price is $16.0265. Telix Pharmaceuticals's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2024 was $0.08. Hence, Telix Pharmaceuticals's Price-to-Operating-Cash-Flow Ratio for today is 190.79.

The historical rank and industry rank for Telix Pharmaceuticals's Price-to-Operating-Cash-Flow or its related term are showing as below:

TLPPF' s Price-to-Operating-Cash-Flow Range Over the Past 10 Years
Min: 129.05 Med: 284.6 Max: 996.25
Current: 207.14

During the past 10 years, Telix Pharmaceuticals's highest Price-to-Operating-Cash-Flow Ratio was 996.25. The lowest was 129.05. And the median was 284.60.

TLPPF's Price-to-Operating-Cash-Flow is ranked worse than
93.44% of 305 companies
in the Biotechnology industry
Industry Median: 24.1 vs TLPPF: 207.14

Telix Pharmaceuticals's Cash Flow from Operations per share for the six months ended in Dec. 2024 was $0.01. Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2024 was $0.08.

During the past 12 months, the average Operating Cash Flow per Share Growth Rate of Telix Pharmaceuticals was 68.90% per year.

During the past 10 years, Telix Pharmaceuticals's highest 3-Year average Operating Cash Flow per Share Growth Rate was 109.90% per year. The lowest was -27.20% per year. And the median was -26.80% per year.

Telix Pharmaceuticals Price-to-Operating-Cash-Flow Historical Data

The historical data trend for Telix Pharmaceuticals's Price-to-Operating-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Telix Pharmaceuticals Price-to-Operating-Cash-Flow Chart

Telix Pharmaceuticals Annual Data

Trend

Sep99

Sep00

Jun17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Price-to-Operating-Cash-Flow

Get a 7-Day Free Trial

472.50

136.22

196.88

Telix Pharmaceuticals Semi-Annual Data
	Sep00	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
Price-to-Operating-Cash-Flow	Get a 7-Day Free Trial												-	-	136.22	-	196.88

Competitive Comparison of Telix Pharmaceuticals's Price-to-Operating-Cash-Flow

For the Biotechnology subindustry, Telix Pharmaceuticals's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Telix Pharmaceuticals's Price-to-Operating-Cash-Flow Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Telix Pharmaceuticals's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Telix Pharmaceuticals's Price-to-Operating-Cash-Flow falls into.

Save Embed

;

Save Embed

;

Telix Pharmaceuticals Price-to-Operating-Cash-Flow Calculation

Telix Pharmaceuticals's Price-to-Operating-Cash-Flow ratio for today is calculated as

Price-to-Operating-Cash-Flow Ratio	=	Share Price	/	Cash Flow from Operations per share (TTM)
	=	16.0265	/	0.084
	=	190.79

Telix Pharmaceuticals's Share Price of today is $16.0265.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Telix Pharmaceuticals's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2024 was $0.08.

Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).

It can also be calculated from the numbers for the whole company:

Price-to-Operating-Cash-Flow Ratio

Market Cap

Cash Flow from Operations

Telix Pharmaceuticals Price-to-Operating-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Telix Pharmaceuticals's Price-to-Operating-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.

Telix Pharmaceuticals Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Telix Pharmaceuticals Ltd (OTCPK:TLPPF) » Definitions » Price-to-Operating-Cash-Flow

Comparable Companies

Traded in Other Exchanges

TLX:USA T3X:Germany TLX:Australia

Address

55 Flemington Road, Suite 401, North Melbourne, Melbourne, VIC, AUS, 3051

Website

https://www.telixpharma.com

Telix develops radiopharmaceuticals to manage cancer. Radiopharmaceuticals are radioisotopes bound to molecules that can target specific cells. At low doses, these drugs can bind to specific cancer cells with radiation, and then positron emission tomography imaging can accurately visualize tumors. At high doses, these drugs can selectively target and treat tumors with radiation, known as radioligand therapy. Radiopharmaceuticals are usually injected into the bloodstream. Telix has a pipeline of potential radiopharmaceuticals but currently earns most of its revenue from US sales of Illuccix, largely used as an imaging agent to visualize the spread of prostate cancer.